Tackling antibiotic resistance in febrile neutropenia: current challenges with and recommendations for managing infections with resistant Gram-negative organisms

References

• Nesher L, Rolston KV. The current spectrum of infection in cancer patients with chemotherapy related neutropenia. Infection 2014;42(1):5-13
   PubMed Web of Science ®Google Scholar
• Gea-Banacloche J. Evidence-based approach to treatment of febrile neutropenia in hematologic malignancies. Hematology Am Soc Hematol Educ Program 2013;2013:414-22
   PubMedGoogle Scholar
• Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis 2011;52(4):e56-93
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003;36(9):1103-10
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Trecarichi EM, Caira M, et al. Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality. PLoS One 2012;7(12):e51612
   PubMedGoogle Scholar
• Montassier E, Batard E, Gastinne T, et al. Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis 2013;32(7):841-50
   PubMed Web of Science ®Google Scholar
• Gudiol C, Carratala J. Antibiotic resistance in cancer patients. Expert Rev Anti Infect Ther 2014;12(8):1003-16
   PubMed Web of Science ®Google Scholar
• European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters, version 1.1. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_5 0_Breakpoint_Table_01 pdf [Last accessed 1 January 2015]
   Google Scholar
• Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 19th informational supplement. Document M 100-S19 Clinical Laboratory Standards Institute; Wayne, PA: 2009
   Google Scholar
• Averbuch D, Cordonnier C, Livermore DM, et al. Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011). Haematologica 2013;98(12):1836-47
   PubMed Web of Science ®Google Scholar
• Mattner F, Bange FC, Meyer E, et al. Preventing the spread of multidrug-resistant gram-negative pathogens: recommendations of an expert panel of the German Society For Hygiene and Microbiology. Dtsch Arztebl Int 2012;109(3):39-45
   PubMed Web of Science ®Google Scholar
• Garnica M, Maiolino A, Nucci M. Factors associated with bacteremia due to multidrug-resistant Gram-negative bacilli in hematopoietic stem cell transplant recipients. Braz J Med Biol Res 2009;42(3):289-93
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18(3):268-81
   PubMed Web of Science ®Google Scholar
• Mouton JW, Ambrose PG, Canton R, et al. Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective. Drug Resist Updat 2011;14(2):107-17
   PubMed Web of Science ®Google Scholar
• Ruhnke M, Arnold R, Gastmeier P. Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria. Lancet Oncol 2014;15(13):e606-19
   PubMed Web of Science ®Google Scholar
• Klastersky J, Ameye L, Maertens J, et al. Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents 2007;30(Suppl 1):S51-9
   PubMed Web of Science ®Google Scholar
• Blennow O, Ljungman P, Sparrelid E, et al. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations. Transpl Infect Dis 2014;16(1):106-14
   PubMed Web of Science ®Google Scholar
• Aust C, Tolfvenstam T, Broliden K, et al. Bacteremia in Swedish hematological patients with febrile neutropenia: bacterial spectrum and antimicrobial resistance patterns. Scand J Infect Dis 2013;45(4):285-91
   PubMed Web of Science ®Google Scholar
• Ram R, Farbman L, Leibovici L, et al. Characteristics of initial compared with subsequent bacterial infections among hospitalised haemato-oncological patients. Int J Antimicrob Agents 2012;40(2):123-6
   PubMed Web of Science ®Google Scholar
• Castagnola E, Fontana V, Caviglia I, et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis 2007;45(10):1296-304
   PubMed Web of Science ®Google Scholar
• Vernant JP, Thibault M, Cordonnier C, et al. Bacterial septicemia in neutropenia patients. Ann Med Interne (Paris) 1983;134(7):629-35
   PubMedGoogle Scholar
• Cattaneo C, Antoniazzi F, Casari S, et al. P. aeruginosa bloodstream infections among hematological patients: an old or new question? Ann Hematol 2012;91(8):1299-304
   PubMed Web of Science ®Google Scholar
• Vigil KJ, Adachi JA, Aboufaycal H, et al. Multidrug-resistant Escherichia coli bacteremia in cancer patients. Am J Infect Control 2009;37(9):741-5
   PubMed Web of Science ®Google Scholar
• Dobbs TE, Guh AY, Oakes P, et al. Outbreak of Pseudomonas aeruginosa and Klebsiella pneumoniae bloodstream infections at an outpatient chemotherapy center. Am J Infect Control 2014;42(7):731-4
   PubMed Web of Science ®Google Scholar
• Nagao M, Iinuma Y, Igawa J, et al. Control of an outbreak of carbapenem-resistant Pseudomonas aeruginosa in a haemato-oncology unit. J Hosp Infect 2011;79(1):49-53
   PubMed Web of Science ®Google Scholar
• Sood P, Seth T, Kapil A, et al. Emergence of multidrug resistant acinetobacter blood stream infections in febrile neutropenia patients with haematological cancers and bone marrow failure syndromes. J Indian Med Assoc 2012;110(7):439-44
   PubMedGoogle Scholar
• Garazi M, Singer C, Tai J, Ginocchio CC. Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review. J Hosp Infect 2012;81(2):114-18
   PubMed Web of Science ®Google Scholar
• Safdar A, Rolston KV. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis 2007;45(12):1602-9
   PubMed Web of Science ®Google Scholar
• Dignani MC, Grazziutti M, Anaissie E. Stenotrophomonas maltophilia infections. Semin Respir Crit Care Med 2003;24(1):89-98
   PubMed Web of Science ®Google Scholar
• Anaissie EJ, Penzak SR, Dignani MC. The hospital water supply as a source of nosocomial infections: a plea for action. Arch Intern Med 2002;162(13):1483-92
   PubMed Web of Science ®Google Scholar
• Chong Y, Yakushiji H, Ito Y, Kamimura T. Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies. Int J Infect Dis 2011;15(4):e277-81
   PubMed Web of Science ®Google Scholar
• Gudiol C, Bodro M, Simonetti A, et al. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect 2013;19(5):474-9
   PubMed Web of Science ®Google Scholar
• Garnica M, Nouer SA, Pellegrino FL, et al. Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance. BMC Infect Dis 2013;13(1):356
   PubMedGoogle Scholar
• Micozzi A, Venditti M, Monaco M, et al. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 2000;31(3):705-11
   PubMed Web of Science ®Google Scholar
• Vehreschild MJ, Hamprecht A, Peterson L, et al. A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies. J Antimicrob Chemother 2014;69(12):3387-92
   PubMed Web of Science ®Google Scholar
• Kang CI, Chung DR, Ko KS, et al. Risk factors for infection and treatment outcome of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy. Ann Hematol 2012;91(1):115-21
   PubMed Web of Science ®Google Scholar
• Trecarichi EM, Tumbarello M, Spanu T, et al. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J Infect 2009;58(4):299-307
   PubMed Web of Science ®Google Scholar
• Nesher L, Rolston KV, Shah DP, et al. Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2015;17(1):33-8
   PubMed Web of Science ®Google Scholar
• Bodro M, Gudiol C, Garcia-Vidal C, et al. Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients. Support Care Cancer 2014;22(3):603-10
   PubMed Web of Science ®Google Scholar
• Samonis G, Vardakas KZ, Kofteridis DP, et al. Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections. Infection 2014;42(4):721-8
   PubMed Web of Science ®Google Scholar
• Liew YX, Tan TT, Lee W, et al. Risk factors for extreme-drug resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies. Am J Infect Control 2013;41(2):140-4
   PubMed Web of Science ®Google Scholar
• Caselli D, Cesaro S, Ziino O, et al. Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation. Haematologica 2010;95(9):1612-15
   PubMed Web of Science ®Google Scholar
• Kim YA, Choi JY, Kim CK, et al. Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter. Scand J Infect Dis 2008;40(3):234-40
   PubMed Web of Science ®Google Scholar
• Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008;21(3):538-82
   PubMed Web of Science ®Google Scholar
• Mikulska M, Viscoli C, Orasch C, et al. Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients. J Infect 2014;68(4):321-31
   PubMed Web of Science ®Google Scholar
• Macesic N, Morrissey CO, Cheng AC, et al. Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period. Transpl Infect Dis 2014;16(6):887-96
   PubMed Web of Science ®Google Scholar
• Mihu CN, Rhomberg PR, Jones RN, et al. Escherichia coli resistance to quinolones at a comprehensive cancer center. Diagn Microbiol Infect Dis 2010;67(3):266-9
   PubMed Web of Science ®Google Scholar
• Cameron D. Management of chemotherapy-associated febrile neutropenia. Br J Cancer 2009;101(Suppl 1):S18-22
   PubMed Web of Science ®Google Scholar
• Haeusler GM, Mechinaud F, Daley AJ, et al. Antibiotic-resistant Gram-negative bacteremia in pediatric oncology patients–risk factors and outcomes. Pediatr Infect Dis J 2013;32(7):723-6
   PubMed Web of Science ®Google Scholar
• Marin M, Gudiol C, Ardanuy C, et al. Factors influencing mortality in neutropenic patients with haematologic malignancies or solid tumours with bloodstream infection. Clin Microbiol Infect 2015. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Poon LM, Jin J, Chee YL, et al. Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital. Singapore Med J 2012;53(11):720-5
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Spanu T, Caira M, et al. Factors associated with mortality in bacteremic patients with hematologic malignancies. Diagn Microbiol Infect Dis 2009;64(3):320-6
   PubMed Web of Science ®Google Scholar
• Gudiol C, Tubau F, Calatayud L, et al. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother 2011;66(3):657-63
   PubMed Web of Science ®Google Scholar
• Liss BJ, Vehreschild JJ, Cornely OA, et al. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection 2012;40(6):613-19
   PubMed Web of Science ®Google Scholar
• Saghir S, Faiz M, Saleem M, et al. Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan. Indian J Med Microbiol 2009;27(4):341-7
   PubMed Web of Science ®Google Scholar
• Nucci M, Anaissie E. How we treat invasive fungal diseases in patients with acute leukemia: the importance of an individualized approach. Blood 2014;124(26):3858-69
   PubMed Web of Science ®Google Scholar
• Kinnunen U, Syrjala H, Koistinen P, Koskela M. Idarubicin inhibits the growth of bacteria and yeasts in an automated blood culture system. Eur J Clin Microbiol Infect Dis 2009;28(3):301-3
   PubMed Web of Science ®Google Scholar
• Michalopoulos A, Falagas ME, Karatza DC, et al. Epidemiologic, clinical characteristics, and risk factors for adverse outcome in multiresistant gram-negative primary bacteremia of critically ill patients. Am J Infect Control 2011;39(5):396-400
   PubMed Web of Science ®Google Scholar
• Olesen B, Kolmos HJ, Orskov F, Orskov I. Escherichia coli bacteraemia in patients with and without haematological malignancies: a study of strain characters and recurrent episodes. J Infect 1998;36(1):93-100
   PubMed Web of Science ®Google Scholar
• Hakki M, Limaye AP, Kim HW, et al. Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation. Bone Marrow Transplant 2007;39(11):687-93
   PubMed Web of Science ®Google Scholar
• Averbuch D, Orasch C, Cordonnier C, et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica 2013;98(12):1826-35
   PubMed Web of Science ®Google Scholar
• Klastersky J. Infections in immunocompromised patients. I. Pathogenesis, etiology, and diagnosis. Clin Ther 1985;8(1):90-9
   PubMed Web of Science ®Google Scholar
• Cohen ML, Murphy MT, Counts GW, et al. Prediction by surveillance cultures of bacteremia among neutropenic patients treated in a protective environment. J Infect Dis 1983;147(5):789-93
   PubMed Web of Science ®Google Scholar
• Guiot HF, van den Broek PJ, van der Meer JW, van FR. Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebo-controlled study. J Infect Dis 1983;147(4):615-23
   PubMed Web of Science ®Google Scholar
• Wingard JR, Dick J, Charache P, Saral R. Antibiotic-resistant bacteria in surveillance stool cultures of patients with prolonged neutropenia. Antimicrob Agents Chemother 1986;30(3):435-9
   PubMed Web of Science ®Google Scholar
• de Jong PJ, de Jong MD, Kuijper EJ, van der Lelie H. The value of surveillance cultures in neutropenic patients receiving selective intestinal decontamination. Scand J Infect Dis 1993;25(1):107-13
   PubMed Web of Science ®Google Scholar
• Riley DK, Pavia AT, Beatty PG, et al. Surveillance cultures in bone marrow transplant recipients: worthwhile or wasteful? Bone Marrow Transplant 1995;15(3):469-73
   PubMed Web of Science ®Google Scholar
• Leibovici L, Drucker M, Konigsberger H, et al. Septic shock in bacteremic patients: risk factors, features and prognosis. Scand J Infect Dis 1997;29(1):71-5
   PubMed Web of Science ®Google Scholar
• Calfee D, Jenkins SG. Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infect Control Hosp Epidemiol 2008;29(10):966-8
   PubMed Web of Science ®Google Scholar
• Schechner V, Kotlovsky T, Kazma M, et al. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected? Clin Microbiol Infect 2013;19(5):451-6
   PubMed Web of Science ®Google Scholar
• Hess AS, Kleinberg M, Sorkin JD, et al. Prior colonization is associated with increased risk of antibiotic-resistant Gram-negative bacteremia in cancer patients. Diagn Microbiol Infect Dis 2014;79(1):73-6
   PubMed Web of Science ®Google Scholar
• Nguyen A, Heil E, Patel N, et al. A single-center evaluation of the risk for colonization or bacteremia with piperacillin-tazobactam- and cefepime-resistant bacteria in patients with acute leukemia receiving fluoroquinolone prophylaxis. J Oncol Pharm Pract 2015. [Epub ahead of print]
   PubMedGoogle Scholar
• Fisman D, Patrozou E, Carmeli Y, et al. Geographical variability in the likelihood of bloodstream infections due to gram-negative bacteria: correlation with proximity to the equator and health care expenditure. PLoS One 2014;9(12):e114548
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Cataldo MA, Dancer SJ, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014;20(Suppl 1):1-55
   PubMed Web of Science ®Google Scholar
• Pittet D, Allegranzi B, Boyce J. The World Health Organization Guidelines on Hand Hygiene in Health Care and their consensus recommendations. Infect Control Hosp Epidemiol 2009;30(7):611-22
   PubMed Web of Science ®Google Scholar
• Yokoe D, Casper C, Dubberke E, et al. Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated. Bone Marrow Transplant 2009;44(8):495-507
   PubMed Web of Science ®Google Scholar
• Livadiotti S, Milano GM, Serra A, et al. A survey on hematology-oncology pediatric AIEOP centers: prophylaxis, empirical therapy and nursing prevention procedures of infectious complications. Haematologica 2012;97(1):147-50
   PubMed Web of Science ®Google Scholar
• Nucci M, Spector N, Bueno AP, et al. Risk factors and attributable mortality associated with superinfections in neutropenic patients with cancer. Clin Infect Dis 1997;24(4):575-9
   PubMed Web of Science ®Google Scholar
• Giske CG, Monnet DL, Cars O, Carmeli Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 2008;52(3):813-21
   PubMed Web of Science ®Google Scholar
• Wang SS, Lee NY, Hsueh PR, et al. Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae. J Microbiol Immunol Infect 2011;44(4):282-8
   PubMedGoogle Scholar
• Perrone J, Hollander JE, Datner EM. Emergency Department evaluation of patients with fever and chemotherapy-induced neutropenia. J Emerg Med 2004;27(2):115-19
   PubMed Web of Science ®Google Scholar
• Jung JS, Popp C, Sparbier K, et al. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid detection of beta-lactam resistance in Enterobacteriaceae derived from blood cultures. J Clin Microbiol 2014;52(3):924-30
   PubMed Web of Science ®Google Scholar
• Perez F, Adachi J, Bonomo RA. Antibiotic-resistant gram-negative bacterial infections in patients with cancer. Clin Infect Dis 2014;59(Suppl 5):S335-9
   PubMed Web of Science ®Google Scholar
• Marini BL, Hough SM, Gregg KS, et al. Risk factors for piperacillin/tazobactam-resistant Gram-negative infection in hematology/oncology patients with febrile neutropenia. Support Care Cancer 2015. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Fukuta Y, Muder RR, Agha ME, et al. Risk factors for acquisition of multidrug-resistant Acinetobacter baumannii among cancer patients. Am J Infect Control 2013;41(12):1249-52
   PubMed Web of Science ®Google Scholar
• Oliveira AL, de SM, Carvalho-Dias VM, et al. Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2007;39(12):775-81
   PubMed Web of Science ®Google Scholar
• Moghnieh R, Estaitieh N, Mugharbil A, et al. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis. Front Cell Infect Microbiol 2015;5:11
   PubMed Web of Science ®Google Scholar
• Rosa RG, Goldani LZ, dos Santos RP. Risk factors for multidrug-resistant bacteremia in hospitalized cancer patients with febrile neutropenia: a cohort study. Am J Infect Control 2014;42(1):74-6
   PubMed Web of Science ®Google Scholar